Although molecular alterations in EGFR and KRAS occur more frequently in ASC than in MEC, we did not find evidence of these changes being either specific or sensitive enough to use diagnostically and are therefore of little value in tumor classification at this moment. The gene discussed is EGFR; the disease is neoplasm.